Erasca, Inc. ERAS
14.64 USD 0.00 (+0.00%)
At closeNov 4, 2026, 8:55 AM EST
14.80 +0.16 +1.09%
Pre-market · Nov 4, 8:55 AM ET
14.07 Day range 15.00
2.11 52-week range 24.28
- YTD
- +293.55%
- 1 year
- +515.13%
Analyst view
Consensus: buy
Buy
Price target (mean) 24.11 +64.7% upside
Now 14.64
- Target (low)
- 20.00
- Target (mean)
- 24.11
- Target (high)
- 33.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy2
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.13017 | -0.14 – -0.09 | -0.11 | -18.3% | 0 | 0.0% | 8 |
| Next quarter | -0.13228 | -0.17 – -0.07 | -0.10 | -32.3% | 0 | 0.0% | 8 |
| Current year | -0.97619 | -1.06 – -0.86 | -0.44 | -121.9% | 0 | 0.0% | 8 |
| Next year | -0.62318 | -0.80 – -0.34 | -0.97619 | +36.2% | 0 | 0.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Aug 13, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 20, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 14, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jun 4, 2026 | B of A Securities | Upgrade | Underperform | Neutral |
| May 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Apr 27, 2026 | Stifel | Maintained | Buy | Buy |
| Mar 18, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 13, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Mar 13, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Mar 13, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 6, 2026 | Clear Street | Maintained | Buy | Buy |
| Jan 26, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 16, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 13, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 7, 2026 | Piper Sandler | Initiated | — | Overweight |
| Dec 9, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 14, 2025 | Guggenheim | Maintained | Buy | Buy |
| Oct 16, 2025 | Stifel | Initiated | — | Buy |
| Sep 3, 2025 | B of A Securities | Downgrade | Buy | Underperform |
| Aug 18, 2025 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Apr 30, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 26, 2025 | Raymond James | Initiated | — | Outperform |
| Mar 21, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Mar 21, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 7, 2025 | B of A Securities | Upgrade | Neutral | Buy |
| Nov 18, 2024 | Jefferies | Initiated | — | Buy |
| Nov 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |